BPC-157 peptide research contexts
Xiaopeng Z, Jing Y, Xia L et al (2025) Global burden of Alzheimers disease and other dementias in adults aged 65 years and older, 19912021: population-based study
Predicted physicochemical properties supported its hydrophobic character and oral bioavailability, suggesting it is a metabolically stable and BBB-permeable molecule [1]
not trial-validated Endpoint Wrinkle depth Topical timeline 8-12 weeks Injectable framing Anecdotal Endpoint Hair shedding or thickness Topical timeline 12+ weeks Injectable framing Anecdotal
For medical professionals considering BPC-157 in clinical practice, current use must acknowledge the investigational nature of the peptide and proceed within appropriate ethical frameworks including informed consent, safety monitoring, and outcome documentation
'Open doors' Lead researcher Alexis Thompson, professor of paediatrics at Northwestern University, said the results on this larger group of patients were "exciting" and "very promising"